Walleye Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
+1,000
New +$6.12K ﹤0.01% 4482
2026
Q1
Sell
-16,800
Closed -$163K 4890
2025
Q4
$163K Buy
16,800
+14,000
+500% +$119K ﹤0.01% 3642
2025
Q3
$11.7K Buy
+2,800
New +$17.9K ﹤0.01% 4268
2024
Q1
Sell
-1,000
Closed -$8.43K 5819
2023
Q4
$8.43K Buy
+1,000
New +$11.6K ﹤0.01% 4586

Other funds holding REPL

Walleye Capital's REPL Position: Q2 2026 in Review

Walleye Capital reduced its Replimune Group (REPL) stake by 96% in Q2 2026, selling an estimated $421K and leaving 2,729 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4320.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.18M in Q2 2023. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Walleye Capital held 2,729 shares of Replimune Group worth $30.2K as of Q2 2026.
  • Walleye Capital sold 68,863 Replimune Group shares in Q2 2026, an estimated $421K.
  • Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4320 holding.
  • Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 7 quarters since.
  • Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.